Micromax pips Samsung as India's leading mobile phone brand - research
MUMBAI (Reuters) - Indian budget smartphone maker Micromax has ousted Samsung Electronics Co Ltd as the leading brand in all types of mobile phones in the April-June quarter, grabbing a 16.6 percent market share, a recent research report showed.
Samsung had 14.4 percent market share, down from 16.3 percent in the first quarter, said the report by Counterpoint Research. In the smartphone segment, however, Samsung still came out tops.
"Micromax is leveraging its wider distribution reach, growing brand awareness not only in urban but in rural India with affordable low-cost handsets," said Counterpoint analyst Neil Shah.
In price sensitive India, local mobile phone makers like Micromax are successfully gaining market share with low cost phones.
These companies mostly use chipsets made by MediaTek, which tend to be cheaper than those made by industry leader Qualcomm Inc, and outsource production to China and Taiwan, instead of investing in manufacturing plants, further helping keep costs down.
Together, local Indian mobile phone manufacturers had about 32 percent of the domestic market, according to the report, and more than two-thirds of the total shipments.
In the smartphone segment, Samsung still had the largest market share in terms of shipments, at 25.3 percent during the second quarter while Micromax had 19.1 percent.
But Samsung's dominance is slipping, Shah said, adding that in the first quarter, Samsung had a 33.3 percent market share in smartphones, while Micromax had 16.7 percent.
India ranks behind China and the United States in smartphone sales, with up to 90 million smartphones expected to be sold there this year, according to Counterpoint.
(Reporting by Nivedita Bhattacharjee; Editing by Miral Fahmy)
- Tweet this
- Share this
- Digg this
- Boxer Sarita Devi faces action after refusing medal at Asian Games
- Dallas Ebola patient vomited outside apartment on way to hospital
- Billionaire Detroit business leader says "blight is like a cancer"
- New NATO leader offers olive branch to Russia
- US STOCKS-Wall St down more than 1 pct; small caps extend fall
India could run out of a critical medicine in its free HIV/AIDS drugs programme in three weeks due to bureaucratic bungling, a senior government official said, leaving more than 150,000 sufferers without life-saving drugs for about a month. Full Article